Skip to main content
OpenTrials
Completed

NCT Number: NCT06906965

Effect of the Imera Cultivar Carob in Postprandial Glycemia

An acute randomized crossover study on the effect of a carob beverage on postprandial glycemic response

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Postprandial Glucose Regulation

Age range

18 year and older

Sex eligibility

Male

Study type

Interventional

Phase

Not applicable

Primary location

Department of Nutrition and Dietetics, HarokopioUniversity of Athens

Kallithea, Attica, 17676, Greece

About this study

This is an acute randomized crossover study on the effect of an Imera cultivar carob beverage on postprandial glycemic response in healthy individuals as opposed to sucrose-based beverage containing sugar in alike concentration

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • healthy male adults of normal body fat mass

Exclusion criteria

  • obesity (according to body fat mass), type 1 Diabetes, hypertension and other cardiovascular diseases, thyroid disorder, liver, kidney, gastrointestinal disease, mental illness, use of nutraceutical supplements or natural products for weight loss and the background of dietitian/nutritionist.

Treatment and study plan

Carob beverage

Other

The participants consumed a carob beverage made with 30gr of Imera carob cultivar powder in water

Sucrose beverage

Other

The participants consumed a sucrose beverage made with 14gr of sugar in alike concentration with sugars in the experimental beverage

Primary outcomes

  1. Postprandial glucose

    Time frame: 3 hours

    Changes in glucose levels after the consumption of the beverage

Secondary outcomes

  1. Postprandial insulin

    Time frame: 3 hours

    Changes in insulin levels after consuming the beverage

Sponsors and collaborators

Lead sponsor

Harokopio University

Other

Registry information

Official study title

Impact of the Imera Carob Cultivar in Postprandial Glycemia

Acronym: IMERACAROBGLUC

Important dates

Study start
2024
Primary completion
2024
Study completion
2024
First posted
Apr 2, 2025
Registry last updated
Apr 6, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.